Technology-Enabled Activation of Skin Cancer Screening for Stem Cell

Status Active, not recruiting

Clinical Trial Summary

This trial studies the impact of a 12-month invention focused on early detection of skin cancer and timely follow up in patients who underwent stem cell transplant and their primary care providers. Some stem cell transplant survivors may develop complications related to the treatment they received. Many of these complications may not be known for years after the treatment and preventive measures can be taken to reduce the chances that a complication will occur and encourage early detection. This study focuses on one complication that stem cell transplant survivors are at high risk of developing - skin cancer. An early diagnosis of skin cancer is important since the cancer is usually smaller, requires less extensive treatments, and has better outcomes. Teaching skin self-examination and encouraging patients to alert doctors to skin changes may provide an important opportunity for early detection of skin cancer.

Clinical Trial Description

PRIMARY OBJECTIVES: I. Determine the impact of patient activation and education (PAE, N=360) alone or with physician activation (PAE+Phys, N=360) on skin cancer screening and health promotion practices at 12 months, measured by percentage of survivors who conduct skin self-exam and receive physician skin exam, and time to detection and diagnosis of suspicious lesions. II. Among primary care physicians of transplant patients, determine the impact of an e-learning teledermoscopy program compared with provision of print materials for identifying suspect lesions. OUTLINE: Participants are randomized to 1 of 3 groups. GROUP I: Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months. GROUP II: Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months. Participants' physician receives a letter that describes the educational intervention and encourages them to do a skin examination at next patient visit. GROUP III: Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months. Participants' physician receives a letter that describes the educational intervention and encourages them to do a skin examination at next patient visit. Physicians also receive a free dermatoscope with instructions for uploading images of suspect lesions and attend a 30-minute online course comprising additional descriptions of dermoscopic images for skin cancers and "mimickers" common in hematopoietic stem cell transplantation patients, along with clear instructions for using a dermatoscope and steps to integrate dermoscopy into their practice. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04358276
Study type	Interventional
Source	City of Hope Medical Center
Contact
Status	Active, not recruiting
Phase	N/A
Start date	October 30, 2020
Completion date	March 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01242618` - Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule	Phase 1
Not yet recruiting	`NCT06167096` - Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery	N/A
Recruiting	`NCT03699995` - MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma	N/A
Completed	`NCT04456140` - Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study	Phase 1
Terminated	`NCT03630601` - Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers	N/A
Recruiting	`NCT03543969` - Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma	Early Phase 1
Completed	`NCT00783965` - Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back	Phase 2
Recruiting	`NCT04475640` - Cancer Genetic Testing in Ethnic Populations	N/A
Active, not recruiting	`NCT02465060` - Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	Phase 2
Completed	`NCT03177057` - SMART Project in Preventing Skin Cancer	N/A
Completed	`NCT02417948` - Improving Sun-Protective Behaviors and Skin Self-Examinations Among African Americans	N/A
Completed	`NCT03290989` - Itch and Pain Characteristics in Skin Carcinomas	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms